← Back to Search

Stromal Vascular Fraction

GID SVF-2 for Erectile Dysfunction

N/A
Waitlist Available
Research Sponsored by GID BIO, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will test if a single injection of a person's own fat cells can improve erectile dysfunction.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events
Secondary outcome measures
International Index of Erectile Function (IIEF)
Other outcome measures
Partner Satisfaction Questionnaire

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Each subject will receive a single injection of autologous adipose-derived stromal vascular fraction (SVF) and will be monitored for 6 months
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GID SVF-2
2016
N/A
~50

Find a Location

Who is running the clinical trial?

GID BIO, Inc.Lead Sponsor
4 Previous Clinical Trials
180 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Tennessee
North Carolina
How old are they?
18 - 65
What site did they apply to?
David Matthews MD
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~2 spots leftby Apr 2025